Alanyl-glutamine supplementation regulates mTOR and ubiquitin proteasome proteolysis signaling pathways in piglets

Nutrition

Volumn 32, Issue 10, 2016, Pages 1123-1131

  Zhang, Bolin ^a,b   Lin, Meng ^a   Yu, Changning ^a   Li, Jiaolong ^a   Zhang, Lin ^a   Zhou, Ping ^a   Yang, Wenwei ^c   Gao, Feng ^a   Zhou, Guanghong ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b ZUNYI NORMAL COLLEGE   (China)

^c Center for Animal Disease Control and Prevention of Jintan   (China)

Author keywords

Alanyl glutamine; Glutaminolysis; mTOR signaling; Piglet; Ubiquitin proteasome proteolysis signaling

Indexed keywords

ALANINE; ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GLUTAMATE AMMONIA LIGASE; GLUTAMATE DEHYDROGENASE; GLUTAMINASE; GLUTAMINE; INITIATION FACTOR 4E BINDING PROTEIN 1; MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; PHOSPHOTRANSFERASE; PROTEASOME; PROTEIN S6 KINASE 1; UBIQUITIN PROTEASOME; UNCLASSIFIED DRUG; ALANYLGLUTAMINE; DIPEPTIDE; GLUTAMIC ACID; TARGET OF RAPAMYCIN KINASE; UBIQUITIN;

AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL TISSUE; ARTICLE; BODY GROWTH; CONTROLLED STUDY; DIET SUPPLEMENTATION; GENE; LIVER PARENCHYMA; MAFBX GENE; MURF1 GENE; NONHUMAN; PIGLET; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; WEIGHT GAIN; ANIMAL; DIETARY SUPPLEMENT; DRUG EFFECTS; GENETICS; LIVER; MALE; METABOLISM; PIG;

ALANINE; ALANINE TRANSAMINASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; DIETARY SUPPLEMENTS; DIPEPTIDES; GLUTAMATE DEHYDROGENASE; GLUTAMATE-AMMONIA LIGASE; GLUTAMIC ACID; GLUTAMINASE; GLUTAMINE; LIVER; MALE; MUSCLE, SKELETAL; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEOLYSIS; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUS SCROFA; TOR SERINE-THREONINE KINASES; UBIQUITINS; WEIGHT GAIN;

EID: 84964905706     PISSN: 08999007     EISSN: 18731244     Source Type: Journal    
DOI: 10.1016/j.nut.2016.02.023     Document Type: Article

References (49)

1. [1] Reeds, P.J., Burrin, D.G., Glutamine and the bowel. J Nutr 131 (2001), 2505S–2508S.
2. [2] Tirapegui, J., Cruzat, V.F., Glutamine and skeletal muscle. Rajendram, R., Preedy, V.R., Vinood, V., (eds.) Glutamine in clinical nutrition, 2015, Springer, New York, 499–511.
3. [3] Klassen, P., Mazariegos, M., Solomons, N.W., Fürst, P., The pharmacokinetic responses of humans to 20 g of alanyl-glutamine dipeptide differ with the dosing protocol but not with gastric acidity or in patients with acute dengue fever. J Nutr 130 (2000), 177–182.
4. [4] Rogero, M.M., Tirapegui, J., Pedrosa, R.G., de Castro, I.A., de Oliveira Pires, I.S., Effect of alanyl-glutamine supplementation on plasma and tissue glutamine concentrations in rats submitted to exhaustive exercise. Nutrition 22 (2006), 564–571.
5. [5] Cruzat, V.F., Krause, M., Newsholme, P., Amino acid supplementation and impact on immune function in the context of exercise. J Int Soc Sports Nutr, 11, 2014, 61.
6. [6] Wu, G., Recent advances in swine amino acid nutrition. J Anim Sci Biotechnol 1 (2010), 118–130.
7. [7] Zhong, X., Zhang, X., Li, X., Zhou, Y., Li, W., Huang, X., et al. Intestinal growth and morphology is associated with the increase in heat shock protein 70 expression in weaning piglets through supplementation with glutamine. J Anim Sci 89 (2011), 3634–3642.
8. [8] Haynes, T.E., Li, P., Li, X., Shimotori, K., Sato, H., Flynn, N.E., et al. L-glutamine or L-alanyl-L-glutamine prevents oxidant-or endotoxin-induced death of neonatal enterocytes. Amino Acids 37 (2009), 131–142.
9. [9] Vinnars, E., Hammarqvist, F., von der Decken, A., Wernerman, J., Role of glutamine and its analogs in posttraumatic muscle protein and amino acid metabolism. JPEN J Parenter Enter Nutr 14 (1990), 125S–1259S.
10. [10] Curi, R., Lagranha, C.J., Doi, S.Q., Sellitti, D.F., Procopio, J., Pithon-Curi, T.C., et al. Molecular mechanisms of glutamine action. J Cell Physiol 204 (2005), 392–401.
11. [11] MacLennan, P.A., Brown, R., Rennie, M.J., A positive relationship between protein synthetic rate and intracellular glutamine concentration in perfused rat skeletal muscle. FEBS Lett 215 (1987), 187–191.
12. [12] Watford, M., Wu, G., Glutamine metabolism in uricotelic species: variation in skeletal muscle glutamine synthetase, glutaminase, glutamine levels and rates of protein synthesis. Comp Biochem Phys B 140 (2005), 607–614.
13. [13] Watford, M., Glutamine and glutamate metabolism across the liver sinusoid. J Nutr 130 (2000), 983S–987S.
14. [14] Zhou X. Glutamine metabolism and function in skeletal muscle. Unpublished doctorate thesis, The University of British Columbia, Vancouver; 1996. Available at: https://open.library.ubc.ca/cIRcle/collections/ubctheses/831/items/1.0087863. Accessed March 29, 2016.
15. [15] Labow, B.I., Souba, W.W., Abcouwer, S.F., Mechanisms governing the expression of the enzymes of glutamine metabolism-glutaminase and glutamine synthetase. J Nutr 131 (2001), 2467S–2474S.
16. [16] Davis, T.A., Fiorotto, M.L., Beckett, P.R., Burrin, D.G., Reeds, P.J., Wray-Cahen, D., et al. Differential effects of insulin on peripheral and visceral tissue protein synthesis in neonatal pigs. Am J Physiol-Endoc M 280 (2001), E770–E779.
17. [17] Xi, P., Jiang, Z., Dai, Z., Li, X., Yao, K., Zheng, C., et al. Regulation of protein turnover by L-glutamine in porcine intestinal epithelial cells. J Nutr Biochem 23 (2012), 1012–1017.
18. [18] Dann, S.G., Thomas, G., The amino acid sensitive TOR pathway from yeast to mammals. FEBS Lett 580 (2006), 2821–2829.
19. [19] Nakajo, T., Yamatsuji, T., Ban, H., Shigemitsu, K., Haisa, M., Motoki, T., et al. Glutamine is a key regulator for amino acid-controlled cell growth through the mTOR signaling pathway in rat intestinal epithelial cells. Biochem Bioph Res Commun 326 (2004), 174–180.
20. [20] Duran, R.V., Oppliger, W., Robitaille, A.M., Heiserich, L., Skendaj, R., Gottlieb, E., et al. Glutaminolysis activates Rag-mTORC1 signaling. Mol Cell 47 (2012), 349–358.
21. [21] Lecker, S.H., Jagoe, R.T., Gilbert, A., Gomes, M., Baracos, V., Bailey, J., et al. Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression. Faseb J 18 (2004), 39–51.
22. [22] Lambertucci, A.C., Lambertucci, R.H., Hirabara, S.M., Curi, R., Moriscot, A.S., Alba-Loureiro, T.C., et al. Glutamine supplementation stimulates protein-synthetic and inhibits protein-degradative signaling pathways in skeletal muscle of diabetic rats. PLoS One, 7, 2012, e50390.
23. [23] Zhang, B., Yu, C., Lin, M., Fu, Y., Zhang, L., Meng, M., et al. Regulation of skeletal muscle protein synthetic and degradative signaling by alanyl-glutamine in piglets challenged with Escherichia coli lipopolysaccharide. Nutrition 31 (2015), 749–756.
24. [24] National Research Council. Nutrient requirements of swine. 2012, National Academic Press, Washington DC.
25. [25] Kim, S.W., McPherson, R.L., Wu, G., Dietary arginine supplementation enhances the growth of milk-fed young pigs. J Nutr 134 (2004), 625–630.
26. [26] Wang, J., Chen, L., Li, P., Li, X., Zhou, H., Wang, F., et al. Gene expression is altered in piglet small intestine by weaning and dietary glutamine supplementation. J Nutr 138 (2008), 1025–1032.
27. [27] Sahlin, K., Katz, A., Broberg, S., Tricarboxylic acid cycle intermediates in human muscle during prolonged exercise. Am J Physiol-Cell P 259 (1990), C834–C841.
28. −ΔΔCT method. Methods 25 (2001), 402–408.
29. [29] Pawłowska, M., Piedra, J.L.V., Filip, R., Szymanczyk, S.E., Kapica, M., Puzio, I., et al. Effects of L-alanyl-L-glutamine dipeptide administration during 35 days of postnatal life on intestinal mucosa, bone properties, and performance of piglets in their early post-weaning period. Bull Vet Inst Pulawy 51 (2007), 125–129.
30. [30] Wu, G., Meier, S.A., Knabe, D.A., Dietary glutamine supplementation prevents jejunal atrophy in weaned pigs. J Nutr 126 (1996), 2578–2584.
31. [31] Hsu, C., Lee, J., Huang, H., Wang, C., Lee, T., Yen, H., et al. effects of supplemental glutamine on growth performance, plasma parameters and LPS-induced immune response of weaned barrows after castration. Asian-Aust J Anim Sci 25 (2012), 674–681.
32. [32] Newsholme, P., Lima, M., Procopio, J., Pithon-Curi, T., Bazotte, R., Curi, R., Glutamine and glutamate as vital metabolites. Braz J Med Biol Res 36 (2003), 153–163.
33. [33] Cruzat, V.F., Bittencourt, A., Scomazzon, S.P., Leite, J.S., de Bittencourt, P.I. Jr., Tirapegui, J., Oral free and dipeptide forms of glutamine supplementation attenuate oxidative stress and inflammation induced by endotoxemia. Nutrition 30 (2014), 602–611.
34. [34] Cruzat, V.F., Rogero, M.M., Tirapegui, J., Effects of supplementation with free glutamine and the dipeptide alanyl-glutamine on parameters of muscle damage and inflammation in rats submitted to prolonged exercise. Cell Biochem Funct 28 (2010), 24–30.
35. [35] Watford, M., Chellaraj, V., Ismat, A., Brown, P., Raman, P., Hepatic glutamine metabolism. Nutrition 18 (2002), 301–303.
36. [36] Curthoys, N.P., Watford, M., Regulation of glutaminase activity and glutamine metabolism. Annu Rev Nutr 15 (1995), 133–159.
37. [37] Huang, Y.F., Wang, Y., Watford, M., Glutamine directly downregulates glutamine synthetase protein levels in mouse C2 C12 skeletal muscle myotubes. J Nutr 137 (2007), 1357–1362.
38. [38] Xiao, Y.P., Li, X.L., Wu, T.X., Yang, L., Hong, Q.H., Yang, C.M., et al. Effects of dietary glutamine supplementation on nutrient absorption and activity of enzymes involved in glutamine metabolism and energy production in the jejunum of weaned piglets. J Anim Vet Adv 11 (2012), 1441–1449.
39. [39] Minami, H., Morse, E.L., Adibi, S.A., Characteristics and mechanism of glutamine-dipeptide absorption in human intestine. Gastroenterology 103 (1992), 3–11.
40. [40] Adibi, S.A., Schenker, S., Morse, E., Mechanism of clearance and transfer of dipeptides by perfused human placenta. Am J Physiol-Endoc M 271 (1996), E535–E540.
41. [41] Asnaghi, L., Bruno, P., Priulla, M., Nicolin, A., mTOR: a protein kinase switching between life and death. Pharmacol Res 50 (2004), 545–549.
42. [42] Kim, E., Mechanisms of amino acid sensing in mTOR signaling pathway. Nutr Res Pract 3 (2009), 64–71.
43. [43] Macedo Rogero, M., Tirapegui, J., Pedrosa, R.G., Santana de Oliveira Pires, I., Alves de Castro, I., Plasma and tissue glutamine response to acute and chronic supplementation with L-glutamine and L-alanyl-L-glutamine in rats. Nutr Res 24 (2004), 261–270.
44. [44] Wu, G.Y., Thompson, J.R., The effect of glutamine on protein turnover in chick skeletal muscle in vitro. Biochem J 265 (1990), 593–598.
45. [45] Duran, R.V., Hall, M.N., Glutaminolysis feeds mTORC1. Cell Cycle 11 (2012), 4107–4108.
46. [46] Suryawan, A., Jeyapalan, A.S., Orellana, R.A., Wilson, F.A., Nguyen, H.V., Davis, T.A., Leucine stimulates protein synthesis in skeletal muscle of neonatal pigs by enhancing mTORC1 activation. Am J Physiol-Endoc M 295 (2008), E868–E875.
47. [47] Bodine, S.C., Latres, E., Baumhueter, S., Lai, V.K., Nunez, L., Clarke, B.A., et al. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294 (2001), 1704–1708.
48. [48] Gomes, M.D., Lecker, S.H., Jagoe, R.T., Navon, A., Goldberg, A.L., Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. P Natl Acad Sci U S A 98 (2001), 14440–14445.
49. [49] Herningtyas, E.H., Okimura, Y., Handayaningsih, A.E., Yamamoto, D., Maki, T., Iida, K., et al. Branched-chain amino acids and arginine suppress MaFbx/atrogin-1 mRNA expression via mTOR pathway in C2 C12 cell line. BBA-Gen Subjects 1780 (2008), 1115–1120.